Please note that the list of Invited Speakers is subject to change, and will be updated continuously.
Professor, Emerging Viral Disease Program at Duke-NUS Medical School. His current research is focused on understanding the impact of age in HBV infection/pathology and on the development of new immunological based therapies (TCR-redirected T cells, HLA-peptide specific antibodies) for the treatment of HBV and Hepatocellularcarcinoma.
Professor at the Hepatitis Research Center, National Taiwan University Hospital. His areas of expertise and research interests include Molecular Biology of Hepatitis Viruses, Liver carcinogenesis, prevention and treatment of chronic viral hepatitis.
Principal Investigator in IMCB, joint Principal Investigator in National Cancer Centre Singapore and adjunct assistant professor in Department of Microbiology, National University of Singapore. His research interest is developing humanized mouse models for the study of human infectious diseases, cancers, autoimmune diseases and stem cells
Associate Professor of Microbiology & Immunology, Indiana University School of Medicine (IUSM). His laboratory focuses on the viral pathogenesis of hepatitis B virus and antiviral discovery.
Prof Karn is Reinberger Professor and Chairman, Molecular Biology and Microbiology, Case Western Reserve University. His research interests include epigenetic control mechanisms which regulate HIV transcription, latency in T-cells and microglial cells and HIV eradication strategy.
Professor Levrero is Professor of Medicine at the Sapienza University in Rome, Italy. He has recently joined the Centre de Recherche en Cancérologie de Lyon (CRCL) in Lyon, France, where he leads a Research Unit on ”Epigenetics and Epigenomics of Hepatocellular Carcinoma”, and the Service d’Hepatologie et Gastroenterologie - Hopital de la Croix Rousse - Hospices Civils de Lyon, France, where he continues his academic practice in hepatology.
Lim Seng Gee
Prof Lim is Director of Hepatology, Dept of Gastroenterology & Hepatology National University Hospital, Chairman of the Singapore Hepatitis Conference, Governing Council Member, International Association for Study of Liver; and Adjunct Principal Investigator, Institute of Molecular and Cell Biology, ASTAR
Prof Locarnini is a Head of Department at Research & Molecular Development, Victorian Infectious Diseases Reference Laboratory, University of Melbourne, WHO Regional Reference Laboratory for Hepatitis B. His research interests include Hepatitis A, B, C, D, E, public health, co-infection with HIV, pathogenesis, cure strategies.
Dr Miller is the Executive Director of the Forum for Collaborative HIV Research (The Forum), a Senior Researcher and Lecturer at the UC Berkeley School of Public Health. A leading expert resolving significant health policy and public health issues, she has extensive experience working with major global and US organizations and agencies involved in HIV, HCV, HBV, CMV, PSC and fatty liver disease research and regulatory policy.
Professor of Medicine and Head of the Liver Unit at the IFI Institute for Interdisciplinary Medicine at the Asklepios Klinik St. George, University of Hamburg, Germany. Professor Petersen is actively involved in laboratory and clinical research in viral hepatitis and coleads a work group for the development of novel antiviral techniques in hepatitis B and C.
Professor Revill is a Senior Medical Scientist at the Victorian Infectious Diseases Reference Laboratory (VIDRL), Section Head of the Molecular Virology Group, Division of Research and Molecular Development and the President of Australasian Centre for Hepatitis Virology.
Tan Meng How
Senior Research Scientist, Genome Institute of Singapore at Agency for Science Technology and Research (A*STAR), Assistant Professor in the School of Chemical and Biomedical Engineering at Nanyang Technological University (NTU), Currently, his laboratory is interested in understanding how biological information hardwired in the genome of living cells can be permanently or transiently altered at both the DNA and RNA levels.
Prof Thimme is the Director of the Department of Medicine II (Gastroenterology, Hepatology, Endocrinology and Infectious Diseases). His research focus lies on the immune responses in hepatitis B virus (HBV) and hepatitis C virus (HCV) infection as well as hepatocellular carcinoma (HCC). His main focuses are the immunological determinants of viral clearance and persistence with a special focus on CD8+ T cells.
Professor at Department of Infectious Diseases, Molecular Virology, University Heidelberg. His research interests include molecular mechanisms of Hepatitis B and Hepatitis D Virus/host interactions with a focus on the early events of infection and development of hepatotropic drugs for the therapy of liver diseases
Professor, Shanghai Public Health Clinical Center, Fudan University, Shanghai, People’s Republic of China, Laboratory of Molecular Virology, Shanghai Medical College, Fudan University, Shanghai